Lluria-Prevatt M et al. |
Effects of perillyl alcohol on melanoma in the TPras mouse model. |
2002 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:12050099
|
Bailey HH et al. |
A phase II trial of daily perillyl alcohol in patients with advanced ovarian cancer: Eastern Cooperative Oncology Group Study E2E96. |
2002 |
Gynecol. Oncol. |
pmid:12051875
|
Murren JR et al. |
Phase I study of perillyl alcohol in patients with refractory malignancies. |
2002 Mar-Apr |
Cancer Biol. Ther. |
pmid:12170772
|
Bardon S et al. |
Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression. |
2002 |
Cancer Lett. |
pmid:12175534
|
Teruszkin Balassiano I et al. |
Effects of perillyl alcohol in glial C6 cell line in vitro and anti-metastatic activity in chorioallantoic membrane model. |
2002 |
Int. J. Mol. Med. |
pmid:12430008
|
Burke YD et al. |
Effects of the isoprenoids perillyl alcohol and farnesol on apoptosis biomarkers in pancreatic cancer chemoprevention. |
2002 Nov-Dec |
Anticancer Res. |
pmid:12530055
|
Holstein SA and Hohl RJ |
Monoterpene regulation of Ras and Ras-related protein expression. |
2003 |
J. Lipid Res. |
pmid:12671036
|
Azzoli CG et al. |
A phase I trial of perillyl alcohol in patients with advanced solid tumors. |
2003 |
Cancer Chemother. Pharmacol. |
pmid:12695855
|
Liston BW et al. |
Perillyl alcohol as a chemopreventive agent in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. |
2003 |
Cancer Res. |
pmid:12750258
|
Meadows SM et al. |
Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer. |
2002 |
Int J Gastrointest Cancer |
pmid:12794248
|